B · Normal
[Adopting Shares: Planning to acquire no less than 20% of the equity of Paipeptide Biotechnology] On September 24th, Adopting Shares (301122.SZ) announced that the company is planning to acquire no less than 20% of the equity of Zhejiang Paipeptide Biotechnology Co., Ltd. by paying cash, and has signed a "Letter of Intent to Acquire" with relevant parties. This transaction is not expected to constitute a major asset restructuring. It is still in the planning stage and is subject to uncertainty.
Comments